Polycystic ovary syndrome (PCOS) is a common endocrine condition in women of reproductive age understudied in non-European populations. In India, PCOS affects the life of up to 19.4 million women of age 14-25 years. Gut microbiome composition might contribute to PCOS susceptibility.
Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine condition affecting women of reproductive age, characterized by hyperandrogenism, oligo-or amenorrhea, and polycystic ovaries on transabdominal ultrasonography. The worldwide prevalence of PCOS among women of fertile age is about 6-18%, and it varies with the use of different diagnostic criteria of PCOS such as the Rotterdam criteria, 2003, or National Institutes of Health (NIH), the European Society of Human Reproductive and Embryology (ESHRE) and the Androgen Excess Society (AES) criteria, 2006 [1] [2] [3] . In India, PCOS affects the life of an estimated 6.5 to 19.4 million women of age 14 to 25, and the prevalence is increasing in parallel with the obesity epidemic [4] . In the 1930-s, PCOS was defined as a gynaecological disorder [5] , however, it is associated with a constellation of metabolic conditions, such as obesity, dyslipidaemia, metabolic syndrome, endothelial dysfunction, inflammation, insulin resistance, hypertension and other cardiovascular risks [6] [7] [8] [9] [10] [11] [12] .
Additionally, infertility, pregnancy complications and depression are frequent complications in patients with PCOS [13] [14] [15] . While the development of PCOS is multifaceted and involves genetic [16, 17] , gestational environment [18] and lifestyle aspects [19] . The precise factors responsible for these key biochemical and metabolic derangements and affecting our surrounding environment as well as internal ecosystems, represented by microbiota among others, remain largely unexplored.
From genetic point of view, the human gut microbiome is a collection of microbial genomes of microorganisms that inhabit the human gut [20] . The human gut microbiome is a complex ecosystem harbouring numerous microbes taking part in essential functions of the host organism [21] . Earlier studies in European and Chinese case and control designs showed differences in diversity and relative abundance of particular taxa. It was shown that relative abundances of bacteria belonging to Bacteroides, Escherichia/Shigella and Streptococcus, were inversely correlated with ghrelin, and positively correlated with testosterone and BMI in Chinese women with PCOS. In addition, relative abundances of Akkermansia and Ruminococcaceae are inversely correlated with body-weight, sex-hormone, and brain-gut peptides, and are decreased in PCOS [22] .The gut microbiota alterations in humans are reportedly associated with obesity [23, 24] .
Additionally, the peripheral insulin sensitivity in metabolic syndrome subjects improved upon transfer of stool from healthy donors, thus suggesting a relationship between the glucose metabolism and gut microbiome [25] . Importantly, gut microbiota and its metabolites can control inflammatory processes, brain gut peptide secretion as well as islet b-cell proliferation hence may lead to excessive accumulation of fat ultimately causing insulin resistance and compensatory hyperinsulinemia [25, 26] . In a female mouse model, the testosterone levels increased upon infecting it with male faecal microbiota compared to unmanipulated females [27] . Host's estrus cycles, sex hormones and morphological changes in ovaries are affected by gut microbial composition of the host [28] . In rats, the pre-natal exposure to high androgen levels in daughters from mothers with PCOS led to dysbiosis in gut microbiome and impairment of the cardiometabolic functions [29] . The association between gut microbiome, obesity and host genetics suggests that certain bacteria predisposing to a healthy or unhealthy metabolic state may be heritable [30] [31] [32] . It is hypothesized that diet might induce bacterial dysbiosis thus leading to inflammation, insulin resistance and hyperandrogenemia in PCOS [33] .
In this study, we profiled the gut microbiome of women with PCOS and healthy controls from Northern India. We dissected the gut microbiome composition in relation to blood biochemistry and hormonal levels. Our study suggests that there are differences in the microbial composition between women with PCOS and healthy controls; two families and seven genera are significantly enriched in PCOS, whereas one family is underrepresented in women with PCOS. for PCOS diagnosis. The healthy controls (non-PCOS) were women having regular cyclicity in their menstrual cycles (21-35 days) , no signs of hyperandrogenism and had normal ovarian morphology as evidenced through transabdominal ultrasonography. Women on antibiotic treatment or were taking contraceptives, steroids, anti-epileptics, insulin sensitizers, protonpump inhibitors, or had any previous history of systemic sickness such as diabetes mellitus, coronary artery disease, non-classical congenital adrenal hyperplasia (NCAH), Cushing syndrome, hyperprolactinemia, thyroid dysfunction, gastrointestinal disease and appendectomy were excluded from the study. The study protocol was approved by the Institutional Ethics Committee (IEC) of SKIMS Kashmir and written informed consent was obtained from all the participants involved in this study.
Material and Methods

Study
Blood biochemistry and hormonal levels.
Fasting blood samples were collected in dry and EDTA coated tubes after 10-12 h fasting. Sera were separated to be used in measuring glucose, lipids, alkaline phosphatase (ALP), aspartate aminotransferase (AST), albumin, creatinine, in addition to hormones (prolactin, thyroid-stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), cortisol, luteinizing hormone (LH), follicle-stimulating hormone (FSH), 17α-hydroxyprogesterone (17α-OHP), and total testosterone). The samples for LH, FSH, TESTO, and 17α-OHP were collected on days 3rd-7th (early follicular phase) of spontaneous cycle. The EDTA-containing aliquot was immediately placed on ice and centrifuged within 30 min; plasma was collected and was stored at -80°C until analysis for further analysis. ALP, AST, creatinine, albumin and lipid measurements were performed using fully automated chemistry analyser (Hitachi 920 at SKIMS). Estimation of serum T3, T4, cortisol, 17α-OHP, TSH, prolactin, LH, FSH and total T4 was done by RIA using commercial kits and according to supplier protocol at SKIMS. Plasma glucose was measured by glucose oxidase peroxidase method.
Stool samples.
Each PCOS patient and healthy participant (non-PCOS) was asked to provide fresh stool sample (approx. 5 grams) within the same week when the blood was collected by using the stool collection and stabilization kit (OMNIgene®•GUT OMR-200, DNA Genotek, Canada) which was given to all the participants. All samples were collected in the morning and were stored at ambient temperature until further processing which took place within the next 60 days. Bioinformatics and quality control. The bioinformatic analysis was performed from raw FASTQ files with paired-end reads created classified operation taxonomic units (OTU) using Ribosomal Database Project Classifier (version/access date) [36] against the Illumina-curated version of GreenGenes reference taxonomy database (version/access date) [37] . OTUs that were detected in more than 1/3 of the sample were considered prevalent OTUs and among those, the ones with > 0.1 % average relative abundance across all subjects were included in analysis.
Statistical analysis
Microbial distance and diversity. Inter-individual microbial distance (Bray-Curtis distance) and diversity (Shannon's diversity index) were calculated using functions vegdist and diversity the R package vegan [38] . We analysed the association between PCOS and i) Bray-Curtis distance using the function adonis in R package vegan, and ii) Shannon's diversity index using Spearman correlation in R. Both analyses were additionally adjusted for stool consistency, day of menstrual cycle at sample collection and sequencing read depth.
Association analyses between individual species, PCOS and hormone levels.
We performed all the analyses at Genus and Family levels for which the proportion of successfully classified reads across samples was over 95%. We used the non-parametric Mann-Whitney Utest [39] to compare median abundancies of each species between PCOS cases and controls. We considered results with a P-value<0.05 as statistically significant.
To account for potential confounding factors, we used the Multivariate Association with Linear Model, MaAsLin, in R [40] , which allows for the use of covariates in the model. In brief, MaAsLin fits a linear model for each species and the variable of interest, here PCOS, after arcsin-squareroot transformation of the proportional values of the species. This transformation has been shown to stabilise variance and normalise proportional data well [40] . The method can also include a boosting step to select factors among a large set of variables to be associated with the species. We turned this feature off since we focused only on one variable of interest, PCOS. We used the default settings of the programme, i.e. minimum relative abundance of 0.01%; minimum percentage of samples in which a feature must have the minimum relative abundance in order not to be removed of 10%; outlier removal by Grubbs test with the significance cut-off used to indicate an outlier at 0.05; multiple test correction by the Benjamini-Hochberg (BH) [41] method; and the threshold to use for significance for the generated q-values (BH FDR) of 0.25. As potential confounders in the model we used stool consistency, read depth, age, day of the menstrual cycle during sample collection and body mass index (BMI).
The linear model analysis with MaAsLin was performed also for LH, FSH, and testosterone levels in cases and controls together, adjusting for stool consistency, read depth, age, day of the menstrual cycle during sample collection and BMI.
For bacteria that showed differential enrichment we performed follow-up analyses to dissect the mechanistic links with PCOS. For this, we used MaAsLin to perform linear regression of the relative abundancies in relation to relevant variables that were available ( Supplementary Table   1 ), including blood glucose levels and BMI. We used the same adjustments as before.
Results
16S rRNA gut microbiome in PCOS
After the quality control of 16S rRNA sequencing, we included in the analysis genetic data for 39 microbiomes of Kashmiri women with/without PCOS ( 
Associations with PCOS at genus and family level
The analyses of the individual species at genus level showed statistically significant (P<0.05) differences between cases and controls for 12 organisms ( Table 2) . The most striking differences were observed for Sarcina (cases vs controls: 0.28% vs. 0.06%), Megasphaera (3.62% vs. 1.17%) and Bifidobacterium (7.7% vs. 3.1%) (Figure 1) . Nine of these bacteria reached FDR corrected statistical significance also in the linear modelling with arcsin-square root transformation and outlier exclusions, with Sarcina, Alkalibacterium, Megasphaera, Collinsella, Paraprevotella, Lactobacillus and Bifidobacterium surviving adjustment for stool consistency, day of menstrual cycle at data collection point, sequencing read depth and age ( Table 2 , Supplementary Table 7 ).
When the model was additionally adjusted for BMI, Lactobacillus did not reach the FDR-corrected level of significance anymore.
Five families showed nominally significant differences between PCOS cases and controls by the Mann-Whitney U-test. These included Peptococcaceae, Bifidobacteriaceae, Lactobacillaceae, Erysipelotrichaceae and Porphyromonadaceae ( Table 3 ). The linear modelling with MaAslin confirmed the associations with Peptococcaceae and Bifidobacteriaceae, and showed additionally a significant association with Aerococcaceae (Figures 2 and 3, Supplementary Figure   1 ). The association with Lactobacillaceae did not survive the adjustments for stool consistency, day of menstrual cycle at data collection point, sequencing read depth and age ( Table 3 , Supplementary Table 2 ).
Quantitative traits and hormonal profiles at genus and family level
The cases were taller, had higher weight, BMI, waist and hip circumference than the controls (Table 1) . They also had higher blood glucose, ALP, albumin, creatinine, prolactin and TSH levels and lower AST levels (Table 1, Supplementary Table 1) .
The quantitative trait analyses detected association between higher fasting blood glucose levels (Supplementary Table 7) . Our follow-up analyses with other phenotypes indicated that Eubacterium was associated with weight (0.003, P=3.8x10 -4 , Q=0.16). For LH, LH to FSH and testosterone, we observed no statistically significant associations for any of the bacterial abundancies (Supplementary Tables 8-11 ).
At family level, we detected an association between increased Peptococcaceae and lower prolactin levels (-0.001, P=4.210 -4 , Q=0.19). Linear regression analysis of hormonal levels and family level relative abundancies did not yield any statistically significant associations ( Supplementary Tables 3-6 ).
Distance and diversity
The correlation between bacterial alpha-diversity was statistically different in PCOS cases compared to the controls (r=0.40, P=0.012, Figure 4A ) when adjusting for stool consistency, day of menstrual cycle at sample collection, and read depth. However, the bacterial diversity was not significantly different in the two studied groups (r=0.22, P=0.18) without using the above adjustments (Figure 4B) . Similarly, we observed no statistically significant differences neither in the unadjusted nor adjusted bacterial compositions between cases and controls as measured by the Bray-Curtis distance (unadjusted P=0.10, adjusted P=0.09). Both at genus and family level, the sequencing yielded a higher mean number of reads in controls as compared to the cases (Table 1) .
Discussion
This is a first investigation of PCOS gut microbiome in women from Kashmir, India. Here, we compared 39 individuals with/without PCOS by their gut microbiome composition and dissected the latter in relation to 33 quantitative endophenotypes. We performed a step-wise association modelling moving from simplistic towards more complex covariate models and identified robust signals both with genus and family level taxonomy. Seven genera and three family-level groups were significantly enriched in PCOS cases, including enrichment at both levels in Bifidobacterium and Bifidobacteriaceae. For the first time, we identified a significant direct association between butyrate producing Eubacterium and follicle-stimulating hormone levels.
Overall, the gut microbiome of women with PCOS has a higher bacterial diversity compared to that of women without PCOS, when measured by Shannon's index. However, women with PCOS also have lower bacterial gene count. In addition, for multiple OTUs, the PCOS cases show higher relative abundancies when compared to the healthy controls.
At the genus level, relative abundances of seven genera including Lactobacillus, Bifidobacterium, Sarcina, Alkalibacterium, Megasphaera, Collinsella and Paraprevotella, are increased in gut microbiome of women with PCOS. Association of Lactobacilius seems to be dependent on BMI, whereas the other genera remained significantly associated after adjustment with BMI. Among those we show that Collinsella and Paraprevotella were associated with higher fasting blood glucose levels, and Paraprevotella and Alkalibacterium further associate with larger hip and waist circumference and weight. Lastly, Eubacterium is positively linked with FSH level. Our study is the first to report Sarcina, Alkalibacterium and Megasphaera in relation to PCOS. At the family level, the gut microbiome of women with PCOS are enriched with Aerococcaceae and Bifidobacteriaceae whereas they harbour lower relative abundance of the family Peptococcaceae when we account for the technical covariates in the statistical models. The associations are not likely to be confounded by the BMI of the participants.
To date, a few observational studies on the gut microbiome of individuals with PCOS exist [20, 22, 28, 42, 43] . Bifidobacterium intake resulted in lower insulin concentration, insulin resistance and higher insulin sensitivity in patients after a 12-week intervention [44] . Relative Bifidobacterium abundance in human gut is known to be driven by lactose intolerance. In lactoseintolerant individuals, lactose is not metabolized in the small intestine and proceeds to the colon where it is fermented by members of the gut microbiome; this fermentation leads to gas production, a major symptom associated with lactose intolerance [45] . Thus, genetic variants that reduce lactase activity can promote the growth of lactose-fermenting bacteria in the colon, but only if the individual consumes dairy products. Taken together with our findings this brings in mind if there is an association between adult type hypolactasia and PCOS. There has been only one small study looking at the association, however it was not replicated [46] . Bifidobacterium abundance in gut is known to associate with favorable metabolic outcomes but, a recent report also showed that not all strains of Bifidobacterium are functional [47] and these strain level differences can only be resolved by metagenomics sequencing.
Collinsella and Paraprevotella were previously reported to be increased in obese controls, in comparison to women with PCOS and non-obese controls in a study with limited sample size indicating that these genera could be more specific to obesity and insulin resistance than the PCOS phenotype [22] . In contradiction with our finding, Lactobacillius, for which we found the association to depend on BMI, was found to be enriched in non-obese controls in comparison to the obese PCOS group in the same study. A randomized controlled study focusing of metabolic benefits synbiotics in PCOS reported that Lactobacillus intake resulted in lower insulin concentration, insulin resistance and higher insulin sensitivity [44] The genera Alkalibacterium and Megasphaera which we found enriched in PCOS samples are also involved in lactic acid fermentation otherwise unknown significance in human gut. Sarcina is a member of the family Clostridiaceae and species from this genus Sarcina ventriculi is an increasingly common grampositive coccus, recognized in gastric biopsies, particularly of patients with delayed gastric emptying [48] .
Eubacterium genus, associated with FSH in our study, contains a prominent human gut symbiont species with its own specific and competitive starch utilization pathway (Eubacterium rectale), but also contains butyrate producing bacteria such as E. limosum, in addition to several other species that fall under Eubacterium. Butyrate, in particular, is involved in a number of beneficial processes to the host, including downregulation of bacterial virulence; maintenance of colonic homeostasis, including acting as an energy source for intestinal epithelial cells; and antiinflammatory effects [49] .
One limitation of our study is the sample size which is comparable to the size of other pilot studies in the field. In order to deal with limited sample size, we also used the non-parametric Mann-Whitney U-test. Although this method does not allow to account for covariates, the associations with families Peptococcaceae, Bifidobacteriaceae and Lactobacillaceae and associations with genera Sarcina, Megasphaera, Bifidobacterium, Paraprevotella and Collinsella turn out to be robust, confirmed by both statistical methods. Another limitation of the study is the lack of resolution; however, this can be avoided by using shotgun metagenomics sequencing in further research. Phylogenetic profile in saliva microbiome is also altered and have lower diversity in PCOS and it is associated with clinical parameters [50] . However, none of these pilot studies were replicated at the genus level. Although association with specific taxa are not replicated yet, the emerging field of faecal microbiota transplantation shows encouraging results in rats, decreasing androgen biosynthesis and normalizing ovarian morphology [28] .
We show an increased abundance of genera involved in lactic acid fermentation in the stool samples of PCOS group. Taken together with known beneficial effects of some of bacterial genera, it is difficult to conclude if these are a cause or consequence of the metabolic disturbances seen in PCOS or if they are specific to Indian women. These findings strengthen the role of gut microbiota in PCOS hormonal levels maintenance and warrants further better powered research. 
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